AAV mediated expression of anti-sense neuropeptide Y cRNA in the arcuate nucleus of rats results in decreased weight gain and food intake

被引:39
作者
Gardiner, JV [1 ]
Kong, WM [1 ]
Ward, H [1 ]
Murphy, KG [1 ]
Dhillo, WS [1 ]
Bloom, SR [1 ]
机构
[1] Univ London Imperial Coll Sci Technol & Med, London W12 0NN, England
关键词
neuropeptide Y; anti-sense; food intake; adeno-associated virus;
D O I
10.1016/j.bbrc.2004.12.113
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Neuropeptide Y (NPY) is the most potent stimulant of feeding when administered by intracerebroventricular injection. Despite this, there is conflicting evidence as to its importance in the regulation of daily food intake and energy balance. It has been suggested that whilst it is important in the response to starvation it has little role in the regulation of daily food intake. To investigate the role of NPY in the regulation of food intake, anti-sense cRNA to NPY was expressed in the arcuate nucleus of adult male rats. The antisense NPY (AS-NPY) construct was initially tested in vitro and there was a decrease of approximately 50% in NPY release from anti-sense treated cells compared to controls (16.3 +/- 2.0 fmol/L [AS-NPY] vs 37.3 +/- 7.7 fmol/L [control], mean SEM p < 0.05). NPY release from hypothalamic explants from anti-sense injected animals was decreased by over 50% compared to those from controls at both 15 and 20 days after AAV injection (15 days 42% +/- 6.5% [AS-NPY] vs 100% +/- 36% [control], 20 days 41% +/- 6% [AS-NPY] vs 100% +/- 27% [control] mean SEM, p < 0.05). In a study lasting for 50 days, weight gain was significantly lower in anti-sense injected animals from day 16 (day 16: 6.25 +/- 1.10 g [AS-NPY] vs 9.42 +/- 0.65 g [control] mean SEM, p < 0.05) and remained so until the end of the study when they had gained approximately 40% less weight than controls (day 50: 52.0 +/- 9.6 g [AS-NPY] vs 82.0 +/- 6.3 g [control] mean SEM, p < 0.01). Cumulative food intake was significantly lower in the anti-sense injected animals from day 23 (day 23: 225.8 +/- 1.9 g [AS-NPY] vs 250.6 +/- 8.7 g [control], mean SEM, p < 0.05) and remained so until the end of the study (day 50: 834.5 +/- 14.8 g [AS-NPY] vs 926.0 +/- 31.7 g [control], mean SEM, p < 0.05). Similarly mean daily food intake was also reduced in the anti-sense injected animals (days 7-14: 24.9 +/- 0.4 g/day [AS-NPY] vs 27.2 +/- 0.4 g/day [control], mean SEM, p < 0.01). These data are supportive of a role for NPY in the regulation of daily food intake as well as in response to starvation. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:1088 / 1093
页数:6
相关论文
共 40 条
[1]   NEUROPEPTIDE-Y DISTRIBUTION IN HUMAN-BRAIN [J].
ADRIAN, TE ;
ALLEN, JM ;
BLOOM, SR ;
GHATEI, MA ;
ROSSOR, MN ;
ROBERTS, GW ;
CROW, TJ ;
TATEMOTO, K ;
POLAK, JM .
NATURE, 1983, 306 (5943) :584-586
[2]   NEUROPEPTIDE-Y DISTRIBUTION IN THE RAT-BRAIN [J].
ALLEN, YS ;
ADRIAN, TE ;
ALLEN, JM ;
TATEMOTO, K ;
CROW, TJ ;
BLOOM, SR ;
POLAK, JM .
SCIENCE, 1983, 221 (4613) :877-879
[3]   Evidence for the existence of distinct central appetite, energy expenditure, and ghrelin stimulation pathways as revealed by hypothalamic site-specific leptin gene therapy [J].
Bagnasco, M ;
Dube, MG ;
Kalra, PS ;
Kalra, SP .
ENDOCRINOLOGY, 2002, 143 (11) :4409-4421
[4]   Trophic action of leptin on hypothalamic neurons that regulate feeding [J].
Bouret, SG ;
Draper, SJ ;
Simerly, RB .
SCIENCE, 2004, 304 (5667) :108-110
[5]   NEUROPEPTIDE-Y AND HUMAN PANCREATIC-POLYPEPTIDE STIMULATE FEEDING-BEHAVIOR IN RATS [J].
CLARK, JT ;
KALRA, PS ;
CROWLEY, WR ;
KALRA, SP .
ENDOCRINOLOGY, 1984, 115 (01) :427-429
[6]   Circadian clocks and natural antisense RNA [J].
Crosthwaite, SK .
FEBS LETTERS, 2004, 567 (01) :49-54
[7]  
Daly Thomas M, 2004, Methods Mol Biol, V246, P157
[8]   The lack of specificity of neuropeptide Y (NPY) antisense oligodeoxynucleotides administered intracerebroventricularly in inhibiting food intake and NPY gene expression in the rat hypothalamus [J].
Dryden, S ;
Pickavance, L ;
Tidd, D ;
Williams, G .
JOURNAL OF ENDOCRINOLOGY, 1998, 157 (01) :169-175
[9]   Central leptin gene therapy blocks high-fat diet-induced weight gain, hyperleptinemia, and hyperinsulinemia - Increase in serum ghrelin levels [J].
Dube, MG ;
Beretta, E ;
Dhillon, H ;
Ueno, N ;
Kalra, PS ;
Kalra, SP .
DIABETES, 2002, 51 (06) :1729-1736
[10]   EFFECT OF CORTICOTROPIN RELEASING HORMONE AND NEUROPEPTIDE-Y ON ELECTROPHYSIOLOGICAL ACTIVITY OF SYMPATHETIC-NERVES TO INTERSCAPULAR BROWN ADIPOSE-TISSUE [J].
EGAWA, M ;
YOSHIMATSU, H ;
BRAY, GA .
NEUROSCIENCE, 1990, 34 (03) :771-775